01/27/2026
This month, we’re putting the spotlight on Eversight for their recent contribution to a landmark NIH-funded corneal transplantation study published in JAMA Ophthalmology.
The study demonstrated that corneas from donors with diabetes achieve transplant outcomes comparable to non-diabetic donors, a finding that could expand the available donor pool and increase access to sight-restoring surgery worldwide.
Eversight’s involvement reflects the vital role eye banks play not only in tissue recovery and distribution, but in advancing the research that informs future standards of care. We’re proud to recognize Eversight as a Vision Share member helping move the field forward through evidence-based innovation.
Read the article here - https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2840288
Learn more about Eversight here - https://visionshare.org/member-list-info/eversight-eye-bank/